Integrated signatures define mutational processes in prostate cancer.

Gruber AJ, Olsen AV, Hernando B, Cheng KCL, Gerhäuser C, Torres M, Favero F, Kiriy D, Fernández-Sanromán Á, Roldan-Romero JM, Barton L, Pellegrina D, Bova GS, Brewer DS, Brook MN, Brors B, Butler A, Cancel-Tassin G, Corcoran NM, Cussenot O, Gihawi A, Girma EG, Gnanapragasam VJ, Hamid AA, Hayes VM, He HH, Hovens CM, Imada EL, Jakobsdottir GM, Jung CH, Khani F, Kote-Jarai Z, Lamy P, Leeman G, Loda M, Lutsik P, Marchionni L, Molania R, Papenfuss AT, Pope B, Queiroz LR, Rausch T, Robinson B, Sahli A, Sørensen KD, Yamaguchi TN, Uhrig S, Xu Y, Zanettini C, Pan Prostate Cancer Group (PPCG), Simon R, Sauter G, Eeles RA, Cooper CS, Bristow RG, Wedge DC, Schlomm T, Macintyre G, Reimand J, Weischenfeldt J

Open source

DOI
10.1038/s41586-026-10468-w
Published
2026 Sep 9
Container
Nature
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41586-026-10468-w,
  title = {Integrated signatures define mutational processes in prostate cancer.},
  author = {Gruber AJ and Olsen AV and Hernando B and Cheng KCL and Gerhäuser C and Torres M and Favero F and Kiriy D and Fernández-Sanromán Á and Roldan-Romero JM and Barton L and Pellegrina D and Bova GS and Brewer DS and Brook MN and Brors B and Butler A and Cancel-Tassin G and Corcoran NM and Cussenot O and Gihawi A and Girma EG and Gnanapragasam VJ and Hamid AA and Hayes VM and He HH and Hovens CM and Imada EL and Jakobsdottir GM and Jung CH and Khani F and Kote-Jarai Z and Lamy P and Leeman G and Loda M and Lutsik P and Marchionni L and Molania R and Papenfuss AT and Pope B and Queiroz LR and Rausch T and Robinson B and Sahli A and Sørensen KD and Yamaguchi TN and Uhrig S and Xu Y and Zanettini C and Pan Prostate Cancer Group (PPCG) and Simon R and Sauter G and Eeles RA and Cooper CS and Bristow RG and Wedge DC and Schlomm T and Macintyre G and Reimand J and Weischenfeldt J},
  year = {2026},
  journal = {Nature},
  doi = {10.1038/s41586-026-10468-w},
  url = {https://doi.org/10.1038/s41586-026-10468-w}
}

RIS

TY  - JOUR
TI  - Integrated signatures define mutational processes in prostate cancer.
AU  - Gruber AJ
AU  - Olsen AV
AU  - Hernando B
AU  - Cheng KCL
AU  - Gerhäuser C
AU  - Torres M
AU  - Favero F
AU  - Kiriy D
AU  - Fernández-Sanromán Á
AU  - Roldan-Romero JM
AU  - Barton L
AU  - Pellegrina D
AU  - Bova GS
AU  - Brewer DS
AU  - Brook MN
AU  - Brors B
AU  - Butler A
AU  - Cancel-Tassin G
AU  - Corcoran NM
AU  - Cussenot O
AU  - Gihawi A
AU  - Girma EG
AU  - Gnanapragasam VJ
AU  - Hamid AA
AU  - Hayes VM
AU  - He HH
AU  - Hovens CM
AU  - Imada EL
AU  - Jakobsdottir GM
AU  - Jung CH
AU  - Khani F
AU  - Kote-Jarai Z
AU  - Lamy P
AU  - Leeman G
AU  - Loda M
AU  - Lutsik P
AU  - Marchionni L
AU  - Molania R
AU  - Papenfuss AT
AU  - Pope B
AU  - Queiroz LR
AU  - Rausch T
AU  - Robinson B
AU  - Sahli A
AU  - Sørensen KD
AU  - Yamaguchi TN
AU  - Uhrig S
AU  - Xu Y
AU  - Zanettini C
AU  - Pan Prostate Cancer Group (PPCG)
AU  - Simon R
AU  - Sauter G
AU  - Eeles RA
AU  - Cooper CS
AU  - Bristow RG
AU  - Wedge DC
AU  - Schlomm T
AU  - Macintyre G
AU  - Reimand J
AU  - Weischenfeldt J
PY  - 2026
JO  - Nature
DO  - 10.1038/s41586-026-10468-w
UR  - https://doi.org/10.1038/s41586-026-10468-w
ER  -

APA

AJ, G., AV, O., B, H., KCL, C., C, G., M, T., F, F., D, K., Á, F., JM, R., L, B., D, P., GS, B., DS, B., MN, B., B, B., A, B., G, C., NM, C., O, C., A, G., EG, G., VJ, G., AA, H., VM, H., HH, H., CM, H., EL, I., GM, J., CH, J., F, K., Z, K., P, L., G, L., M, L., P, L., L, M., R, M., AT, P., B, P., LR, Q., T, R., B, R., A, S., KD, S., TN, Y., S, U., Y, X., C, Z., (PPCG), P. P. C. G., R, S., G, S., RA, E., CS, C., RG, B., DC, W., T, S., G, M., J, R., & J, W. (2026). Integrated signatures define mutational processes in prostate cancer.. Nature. https://doi.org/10.1038/s41586-026-10468-w

Source records